LAUREN TUREK: Open Payments
NPI 1790411452 · PLATTSBURGH, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,638 in 85 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $720 · 2025 $1,638
Food & beverage: $1,638
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $435 |
| Novo Nordisk Inc | 15 | $292 |
| Lilly USA, LLC | 8 | $186 |
| AstraZeneca Pharmaceuticals LP | 9 | $175 |
| Amgen Inc. | 12 | $143 |
| Lundbeck LLC | 6 | $118 |
| Otsuka America Pharmaceutical, Inc. | 4 | $79 |
| PFIZER INC. | 3 | $59 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $29 |
| Exact Sciences Corporation | 1 | $25 |
Products named: QULIPTA, REXULTI, MOUNJARO, UBRELVY, Ozempic, FARXIGA, Rybelsus, KRYSTEXXA.
Industry payments across NY — which companies pay providers there.
